Has Jonathan Eaton, MD received payments from drug or device companies?

Yes. Drug and device makers reported $19,473 in general payments to Jonathan Eaton, MD across 374 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan Eaton, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan Eaton, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan Eaton, MD

Critical Care Medicine · Shreveport, LANPI 1780940320

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (41.3%), consulting fees and education — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Vantive US Healthcare LLC at 59.2% of the total. 2025 is the largest year on record at $13,067, more than ten times the $361 reported in 2019. Among critical care medicine clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,473in general payments, 2019–2025

Across 374 payments — averaging $52.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vantive US Healthcare LLC$12K
Abiomed$1K
AstraZeneca$1K
Actelion Pharmaceuticals US, Inc.$948
Merck$601
Baxter Healthcare$577
plus $3K from 23 others

$86,323in research payments, 2019–2025

Across 3 payments — averaging $28,774 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AstraZeneca$86K

What the payments were for

Consulting fees$6,60034%
Travel & lodging$4222%
Food & beverage$8,05141%
Education$4,40023%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vantive US Healthcare LLC	10	$11,529
Abiomed	23	$1,284
AstraZeneca(2 entities)	59	$1,208
Actelion Pharmaceuticals US, Inc.	64	$948
Merck	38	$601
Baxter Healthcare	8	$577
Boehringer Ingelheim	26	$547
GSK	31	$492
Insmed, Inc.	24	$408
Johnson & Johnson	24	$375
Abbott	2	$253
Takeda Pharmaceuticals U.S.A., Inc.	11	$182
Regeneron Healthcare Solutions, Inc.	7	$137
E.r. Squibb & Sons, L.L.C.	9	$115
Getinge USA Sales, LLC	2	$109
Grifols USA, LLC	4	$99
La Jolla Pharmaceutical Company	4	$77
Pfizer	5	$76
Bayer	4	$75
Mallinckrodt Hospital Products Inc.	4	$71
Gilead	4	$70
Inspire Medical Systems, Inc.	1	$58
Dexcom, Inc.	2	$39
Sanofi	2	$37
Pinnacle Biologics, Inc	1	$28
Genentech USA, Inc.	2	$26
Aurinia Pharma U.S., Inc.	1	$19
Paratek Pharmaceuticals, Inc.	1	$17
Shionogi Inc	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,473 in reported general payments places this provider in the 90th percentile of 72 critical care medicine providers in Louisiana.

See all critical care medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024

$83,349

Medicare patients

140

Services billed

585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Shreveport

Richard MorrisonShreveport$24K
Laurie GrierShreveport$23K
Steven ConradShreveport$15K
Cory MarkhamShreveport$3K
Christopher TrosclairShreveport$3K
Sukhmani BoparaiShreveport$2K
Taylor ConradShreveport$2K
Kevin LangloisShreveport$2K
Aiyasawmy DorairajanShreveport$2K
Ajit AlexanderShreveport$2K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →